Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma

Childhood acute lymphoblastic leukemia

Relapsed and refractory disease after frontline cure rates: blinatumomab, inotuzumab and CD19 CAR-T cells.

Live from ClinicalTrials.gov + PubMed, fetched 2026-11-12 10:21 UTC. Every row links to its source record.

Principal investigators and study chairs named on the registry for childhood acute lymphoblastic leukemia, ranked by a published score: 3 per Phase 2+ trial they lead, 1 per other trial role, 2 per oral or late-breaking talk and 0.5 per poster in our verified 2026 meeting rows, each halved every 24 months. Paper authorship is not scored yet. PubMed counts are author name plus indication, for the top 12; names are as the registry spells them, so a common name can pool several people. Open a row for their trials and links to their papers.

Xiaofan Zhu

Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC

score 6.9

146 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 6.9 = 6.6 leading Phase 2+ trials + 0.2 other trial roles + 0 talks + 0 posters. 4 of 5 trials are Phase 2+.

Arend von Stackelberg

Charité - Universitätsmedizin

score 2.9

3 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 2.9 = 2.9 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 2 of 2 trials are Phase 2+.

Franco Locatelli

IRCSS Ospedale Pediatrico Bambino Gesù

score 2.2

179 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 2.2 = 2.2 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2/Ph3NCT07297914 · Bambino Gesù Hospital and Research Institute · Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

Swati Naik

St. Jude Children's Research Hospital

score 1.4

19 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 1.4 = 0 leading Phase 2+ trials + 1.4 other trial roles + 0 talks + 0 posters. 0 of 2 trials are Phase 2+.

Ben K Watkins

Pediatric Early Phase Clinical Trial Network

score 0.9

0 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.9 = 0 leading Phase 2+ trials + 0.9 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT07498465 · Children's Oncology Group · A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Peter Lang

University Childrens Hospital Tübingen

score 0.8

51 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.8 = 0.8 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph1/Ph2NCT05366218 · University Hospital Tuebingen · Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

Juan Cata

M.D. Anderson Cancer Center

score 0.7

0 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.7 = 0.7 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT05466994 · M.D. Anderson Cancer Center · A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)

Kanhatai Chiengthong

King Chulalongkorn Memorial Hospital

score 0.7

4 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.7 = 0 leading Phase 2+ trials + 0.7 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT07078929 · Chulalongkorn University · Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

Tianyou Wang

Beijing Children's Hospital

score 0.6

59 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.6 = 0.6 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT05334823 · Chongqing Precision Biotech Co., Ltd · A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Yicheng Zhang

Tongji Hospital

score 0.6

256 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.6 = 0.6 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT05334823 · Chongqing Precision Biotech Co., Ltd · A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Tim Flaadt

University Hospital Tuebingen, Department of Pediatrics and Adolescent Medicine

score 0.6

0 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.6 = 0 leading Phase 2+ trials + 0.6 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT07108868 · University Hospital Tuebingen · A Phase I Dose Finding Study of MB-CART2219.1

Wolfgang Bethge

University Hospital Tuebingen, Department of Internal Medicine II

score 0.6

2 papers

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.6 = 0 leading Phase 2+ trials + 0.6 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT07108868 · University Hospital Tuebingen · A Phase I Dose Finding Study of MB-CART2219.1

Brian Ball

City of Hope Medical Center

score 0.5

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.5 = 0 leading Phase 2+ trials + 0.5 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT06575296 · City of Hope Medical Center · Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

Michael P Chu

Cross Cancer Institute

score 0.4

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.4 = 0.4 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph1/Ph2NCT03938987 · University of Alberta · Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

Aimee C. Talleur

St. Jude Children's Research Hospital

score 0.4

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.4 = 0 leading Phase 2+ trials + 0.4 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT04881240 · St. Jude Children's Research Hospital · Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Stephen Gottschalk

St. Jude Children's Research Hospital

score 0.4

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.4 = 0 leading Phase 2+ trials + 0.4 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT04881240 · St. Jude Children's Research Hospital · Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Diana Azzam

Florida International University

score 0.3

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.3 = 0 leading Phase 2+ trials + 0.3 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT05857969 · Florida International University · Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Maggie Fader

Nicklaus Children's Hospital

score 0.3

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.3 = 0 leading Phase 2+ trials + 0.3 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT05857969 · Florida International University · Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Birgit Burkhardt

University Hospital Muenster, Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

score 0.2

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.2 = 0.2 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph3NCT04043494 · University Hospital Muenster · International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

Tanja A Gruber

Stanford Universiy

score 0.2

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.2 = 0 leading Phase 2+ trials + 0.2 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT04996160 · Tanja Andrea Gruber · Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia

Allen Yeoh

National University Hospital, Singapore

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0.1 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT03286634 · National Hospital Organization Nagoya Medical Center · ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Marie Bleakley

Fred Hutch/University of Washington Cancer Consortium

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0.1 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT02220985 · Fred Hutchinson Cancer Center · Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Maro Ohanian

M.D. Anderson Cancer Center

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0.1 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT03136146 · M.D. Anderson Cancer Center · Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Melissa Burns

Dana-Farber Cancer Institute

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0.1 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph3NCT03020030 · Dana-Farber Cancer Institute · Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents

Julie-An Talano

Medical College of Wisconsin

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0 leading Phase 2+ trials + 0.1 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT04049383 · Medical College of Wisconsin · CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

Kara Davis

Stanford University

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0 leading Phase 2+ trials + 0.1 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT04088864 · Kara Lynn Davis · CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

Wendy Stock

University of Chicago

score 0.1

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0.1 = 0 leading Phase 2+ trials + 0.1 other trial roles + 0 talks + 0 posters. 0 of 1 trials are Phase 2+.

Ph1NCT03571321 · University of Chicago · Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Anthony S. Stein

City of Hope Medical Center

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 2 of 2 trials are Phase 2+.

Andrew Place

Dana-Farber Cancer Institute

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT01574274 · Dana-Farber Cancer Institute · SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma

Anne L Angiolillo

Children's Oncology Group

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph3NCT01190930 · Children's Oncology Group · Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Anthony Stein

City of Hope Medical Center

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 2 trials are Phase 2+.

Auayporn P. Nademanee

City of Hope Medical Center

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT00544115 · City of Hope Medical Center · Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Christen Ebens

Masonic Cancer Center, University of Minnesota

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT00357565 · Masonic Cancer Center, University of Minnesota · Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

David T Teachey

Children's Oncology Group

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph3NCT02112916 · National Cancer Institute (NCI) · Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Dolores Grosso

Thomas Jefferson University

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT01760655 · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Farhad Ravandi-Kashani

SWOG Cancer Research Network

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT00792948 · National Cancer Institute (NCI) · Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Joseph Rosenthal

City of Hope Medical Center

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph1/Ph2NCT00544466 · City of Hope Medical Center · Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Lynda Vrooman

Dana-Farber Cancer Institute

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph3NCT00400946 · Dana-Farber Cancer Institute · 05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Neal Flomenberg

Thomas Jefferson University

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph2NCT01760655 · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Patrick A Brown

Children's Oncology Group

score 0

–

Profile: all trials, NIH grants and most cited papers →Papers in childhood acute lymphoblastic leukemia (PubMed)Trial papers only All registered trials naming them (ClinicalTrials.gov)

Score 0 = 0 leading Phase 2+ trials + 0 other trial roles + 0 talks + 0 posters. 1 of 1 trials are Phase 2+.

Ph3NCT02101853 · National Cancer Institute (NCI) · Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia